EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib

Grigorios Theodosiou iD, Åke Svensson iD

Pediatric Dermatology · 2026

DOI: 10.1111/pde.70269 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2026. Verfasst von Grigorios Theodosiou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized, Psoriasis, Pyrimidines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasiform eruptions have been described in patients treated with dupilumab. This case report describes an adolescent with severe atopic dermatitis who developed a widespread psoriasiform dermatitis 8 months after starting dupilumab. His therapy was switched to abrocitinib resulting in near‐complete resolution of the psoriatic lesions with good atopic dermatitis control. This case adds to the limited pediatric literature on dupilumab‐induced psoriasis and highlights abrocitinib as an effective therapeutic alternative capable of addressing both conditions concurrently.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicAntibodies, Monoclonal, HumanizedPsoriasisPyrimidinesAntibodies, MonoclonalHumansAdolescentMaleSeverity of Illness IndexTreatment OutcomeDermatologic Agents

Substanzen

dupilumabAntibodies, Monoclonal, HumanizedPyrimidinesAntibodies, MonoclonalDermatologic Agents

Autor:innen und Institutionen

  • Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Department of Dermatology, Skåne University Hospital, Malmö, Sweden.

ORCID-Profile: Grigorios Theodosiou, Åke Svensson

Zitieren

APA

Theodosiou, G., & Svensson, Å. (2026). Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib. Pediatric Dermatology. https://doi.org/10.1111/pde.70269

Vancouver

Theodosiou G, Svensson Å. Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib. Pediatric Dermatology. 2026. doi:10.1111/pde.70269

BibTeX
@article{Theodosiou2026,
  author = {Theodosiou, Grigorios and Svensson, Åke},
  title = {Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib},
  journal = {Pediatric Dermatology},
  year = {2026},
  doi = {10.1111/pde.70269}
}
Kostenlos starten →